• Ionis, AstraZeneca Stumble in ATTR-CM Trial as Rivals Stand to Gain Benzinga Fri, 10 Jul 2026 15:30:43 GMT
• Ionis Pharmaceuticals (IONS) Shares Drop After Roche Discontinues Trials GuruFocus Fri, 10 Jul 2026 15:04:35 GMT
• IONS Maintained by HC Wainwright & Co. -- Price Target Lowered t GuruFocus Fri, 10 Jul 2026 15:04:35 GMT
• IONS Maintained by Morgan Stanley -- Price Target Lowered to $11 GuruFocus Fri, 10 Jul 2026 14:56:34 GMT
• Roche scraps two Ionis-partnered studies (IONS:NASDAQ) Seeking Alpha Fri, 10 Jul 2026 14:21:13 GMT
• IONS Maintained by Barclays -- Price Target Lowered to $90 GuruFocus Fri, 10 Jul 2026 14:06:21 GMT
• IONS Maintained by Canaccord Genuity -- Price Target Lowered to $95 GuruFocus Fri, 10 Jul 2026 13:08:08 GMT
• IONS SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Ionis Pharmaceuticals Morningstar Fri, 10 Jul 2026 13:00:00 GMT
• AstraZeneca, Ionis’ Wainua woes send waves across ATTR-CM space BioSpace Fri, 10 Jul 2026 12:29:06 GMT
• Canaccord cuts Ionis stock price target on trial miss to $95 Investing.com Fri, 10 Jul 2026 12:17:02 GMT
• Roche scraps 2 Huntington’s studies, handing Ionis more bad news BioSpace Fri, 10 Jul 2026 12:04:06 GMT
• IONS Maintained by Citigroup -- Price Target Lowered to $100 GuruFocus Fri, 10 Jul 2026 12:01:01 GMT
• Barclays cuts Ionis Pharmaceuticals stock price target on trial miss Investing.com Fri, 10 Jul 2026 10:19:34 GMT
• Ionis Pharmaceuticals (NASDAQ: IONS) keeps 2026 financial guidance unchanged Stock Titan Fri, 10 Jul 2026 10:03:19 GMT
• Roche drops two Huntington’s programmes from Ionis European Biotechnology Magazine Fri, 10 Jul 2026 08:39:02 GMT
• Ionis and AstraZeneca: Shares Tank as Phase 3 ATTR-CM Trial Falls Short of Expectations Morningstar Fri, 10 Jul 2026 08:03:00 GMT
• Due to a drug developed in collaboration with AstraZeneca failing to achieve its primary endpoint in a late-stage clinical trial f... Bitget Fri, 10 Jul 2026 07:18:21 GMT
• AstraZeneca (LSE:AZN) Misses Key Wainua Trial Goal Beyond Oncology Yahoo Finance Singapore Fri, 10 Jul 2026 01:23:00 GMT
• Insider Sell: Allene Diaz Sells Shares of Ionis Pharmaceuticals Inc (IONS) GuruFocus Fri, 10 Jul 2026 01:01:48 GMT
• Ionis Pharmaceuticals Investigation Notice: Levi & Korsinsky Notifies Investors of a Pending Investigation Into Ionis Pharmaceutic... Morningstar Fri, 10 Jul 2026 00:57:00 GMT
• Ionis Pharmaceuticals EVP C. Frank Bennett sells $1.7m in stock Investing.com Fri, 10 Jul 2026 00:31:37 GMT
• ionis pharmaceuticals evp c. frank bennett sells $1.7m in stock Investing.com Canada Thu, 09 Jul 2026 23:32:59 GMT
• Ionis (IONS) CSO Frank Bennett sells shares, shifts 15,000 into family trust Stock Titan Thu, 09 Jul 2026 23:26:58 GMT
• Ionis Pharmaceuticals EVP sells $30,516 in stock By Investing.com Investing.com Nigeria Thu, 09 Jul 2026 23:23:02 GMT
• Narrow-Moat Ionis Retains Long-Term Growth Potential Despite Phase 3 ATTR-CM Setback Morningstar Thu, 09 Jul 2026 23:16:20 GMT
• Ionis director Allene Diaz sells $863,637 of common stock Investing.com Thu, 09 Jul 2026 23:16:06 GMT
• Form 4 Ionis Pharmaceuticals Inc For: 9 July By Investing.com Investing.com Nigeria Thu, 09 Jul 2026 22:43:36 GMT
• Ionis Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $97.43, Implies 15% Upside TradingView Thu, 09 Jul 2026 22:20:08 GMT
• Ionis (NASDAQ: IONS) EVP sells 362 shares under Rule 10b5-1 plan Stock Titan Thu, 09 Jul 2026 22:11:31 GMT
• Ionis Pharmaceuticals (NASDAQ: IONS) director sells shares under 10b5-1 plan Stock Titan Thu, 09 Jul 2026 22:08:23 GMT
• Health Care Down on Rotation Out of Defensive Sectors - Health Care Roundup Moomoo Thu, 09 Jul 2026 21:38:09 GMT
• ions maintained by jefferies -- price target lowered to $90 GuruFocus Thu, 09 Jul 2026 21:08:56 GMT
• Phase 3 Failure Keeps AstraZeneca and Ionis Out of a Growing Heart Disease Market MedCity News Thu, 09 Jul 2026 20:30:50 GMT
• why astrazeneca crashed 6%, leading two rivals, including pfizer, to jump Investor's Business Daily Thu, 09 Jul 2026 20:26:00 GMT
• Jefferies cuts Ionis Pharmaceuticals stock price target on trial miss By Investing.com Investing.com South Africa Thu, 09 Jul 2026 20:10:55 GMT
• AstraZeneca And Ionis Pharma Rocked By Heart Disease Fail - Why You Shouldn't Panic (AZN) Seeking Alpha Thu, 09 Jul 2026 19:58:21 GMT
• ionis (nasdaq:ions) shares slump as failed trial triggers $3b selloff TechStock² Thu, 09 Jul 2026 19:51:14 GMT
• ions maintained by needham -- price target lowered to $86.00 GuruFocus Thu, 09 Jul 2026 19:36:29 GMT
• bbio stock surges 16% as astrazeneca-ionis heart drug trial misses goal — bofa calls failure ‘a big surprise’ Yahoo Finance Thu, 09 Jul 2026 19:06:45 GMT
• Ionis Pharmaceuticals (IONS) Phase 3 eplontersen trial in ATTR-CM fails primary goal Stock Titan Thu, 09 Jul 2026 18:55:48 GMT
• AstraZeneca and Ionis' Wainua Misses Primary Endpoint in Phase III ATTR-CM Trial BioPharm International Thu, 09 Jul 2026 18:43:24 GMT
• Roche ends 2 Huntington’s disease programs, including Ionis-partnered tominersen Fierce Biotech Thu, 09 Jul 2026 18:40:16 GMT
• roche ends 2 huntington’s programs, including ionis aso Fierce Biotech Thu, 09 Jul 2026 18:40:16 GMT
• New heart drug from AstraZeneca and Ionis falls short in clinical trial Cardiovascular Business Thu, 09 Jul 2026 17:15:08 GMT
• BofA cuts Ionis Pharmaceuticals stock price target on trial miss By Investing.com Investing.com Nigeria Thu, 09 Jul 2026 17:13:20 GMT
• ionis pharmaceuticals price target lowered to $86 from $105 at needham TipRanks Thu, 09 Jul 2026 16:54:08 GMT
• TD Cowen cuts Ionis stock price target to $94 on trial miss Investing.com Thu, 09 Jul 2026 16:47:00 GMT
• bridgebio hits 52-week high on late-stage trial setback for astra/ ionis (update) Seeking Alpha Thu, 09 Jul 2026 16:29:00 GMT
• Alnylam, BridgeBio Gain From AstraZeneca-Ionis Drug Missing Target -- Market Talk Moomoo Thu, 09 Jul 2026 16:24:42 GMT
• Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy BioWorld News Thu, 09 Jul 2026 16:00:00 GMT
• AstraZeneca, Ionis Stocks Stumble After Heart Drug Fails Key Trial -- WSJ Moomoo Thu, 09 Jul 2026 15:39:05 GMT
• az, ionis shares tumble on attr-cm trial flop, but analyst flags over-reaction Fierce Pharma Thu, 09 Jul 2026 15:36:53 GMT
• gene-silencing drug wainua fails landmark attr-cm trial in astrazeneca setback Tech Times Thu, 09 Jul 2026 15:18:42 GMT
• ionis pharmaceuticals (ions) stock plummets 20% following failed heart disease trial Blockonomi Thu, 09 Jul 2026 14:58:14 GMT
• Ionis Pharmaceuticals Slides as Investors React to Likely Eplontersen Trial Setback Quiver Quantitative Thu, 09 Jul 2026 14:50:00 GMT
• Oppenheimer cuts Ionis Pharmaceuticals stock price target on trial miss Investing.com Thu, 09 Jul 2026 14:37:04 GMT
• Ionis Pharmaceuticals (IONS) Sees Significant Decline in Stock P GuruFocus Thu, 09 Jul 2026 14:34:06 GMT
• Ionis Pharmaceuticals (IONS) Faces Significant Pre-Market Decline of 18.9% GuruFocus Thu, 09 Jul 2026 14:18:04 GMT
• astrazeneca, ionis shares slide after wainua misses target in heart disease trial WSJ Thu, 09 Jul 2026 13:41:00 GMT
• AstraZeneca, Ionis report major trial failure with heart disease drug STAT Thu, 09 Jul 2026 13:00:16 GMT
• major drugmaker loses $27 billion in market value after failed trial MarketWatch Thu, 09 Jul 2026 12:28:00 GMT
• astrazeneca, ionis drug fails big heart disease study in major setback BioPharma Dive Thu, 09 Jul 2026 12:17:37 GMT
• Why Is Ionis Pharmaceuticals, AstraZeneca Stock Tumbling Today? - AstraZeneca (NYSE:AZN), Ionis Pharmaceu Benzinga Thu, 09 Jul 2026 12:09:28 GMT
• astrazeneca stock drops 9% after wainua heart drug trial fails qz.com Thu, 09 Jul 2026 12:09:23 GMT
• Levi Strauss, Ionis Pharmaceuticals, Gloo Holdings And Other Big Stocks Moving Lower In Thursday’s Pre-Ma Benzinga Thu, 09 Jul 2026 12:02:05 GMT
• AstraZeneca Stock and Partner Ionis Sink After Trial Failure. Alnylam Soars. Barron's Thu, 09 Jul 2026 11:38:00 GMT
• Ionis shares expected to fall on failed heart study, Stifel says Investing.com Thu, 09 Jul 2026 11:25:09 GMT
• astrazeneca’s wainua fails key heart disease trial, shares tumble WTVB Thu, 09 Jul 2026 11:13:54 GMT
• Why is Ionis Pharmaceuticals stock plummeting today? By Investing.com Investing.com Nigeria Thu, 09 Jul 2026 11:13:31 GMT
• IONS Stock Heads Toward Biggest Single-Day Slump In Over 5 Years – Retail Calls It ‘Opportunity Of A Lifetime’ Yahoo Finance Thu, 09 Jul 2026 11:11:44 GMT
• stock market today: s&p 500, nasdaq 100 futures rise as us-iran exchange strikes—levi strauss, azz, ionis Benzinga Thu, 09 Jul 2026 09:21:19 GMT
• Ionis Pharmaceuticals Provides Update on CARDIO-TTRansform Phase 3 Trial of Eplontersen in Adults with Transthyretin-Mediated Amyl... marketscreener.com Thu, 09 Jul 2026 08:06:06 GMT
• updated: astrazeneca sinks on unexpected heart drug trial failure Endpoints News Thu, 09 Jul 2026 07:58:00 GMT
• astrazeneca tumbles as heart drug trial misses main efficacy goal (azn:nyse) Seeking Alpha Thu, 09 Jul 2026 07:50:06 GMT
• astrazeneca, ionis' heart disease treatment fails to meet primary endpoint in late-stage trial Moomoo Thu, 09 Jul 2026 07:36:05 GMT
• ionis’ eplontersen fails primary endpoint in heart disease trial Investing.com Thu, 09 Jul 2026 07:19:02 GMT
• Ionis heart drug misses key goal, but monotherapy subgroup hit Stock Titan Thu, 09 Jul 2026 06:30:27 GMT
• astrazeneca's wainua fails key heart disease trial, shares tumble Reuters Thu, 09 Jul 2026 06:12:00 GMT
• astrazeneca-ionis drug fails to meet main goal in late-stage heart disease trial Yahoo Thu, 09 Jul 2026 06:12:00 GMT
• Why Ionis Pharmaceuticals (IONS) Is Up 6.7% After Angelman Phase 3 Pediatric Enrollment Milestone And What's Next simplywall.st Thu, 09 Jul 2026 01:43:41 GMT
• Is Ionis Pharmaceuticals, Inc. (IONS) Stock a Buy After Tryngolza’s FDA Approval? Yahoo Finance Wed, 08 Jul 2026 14:50:29 GMT
• form 144 ionis pharmaceuticals inc for: 7 july by investing.com Investing.com Nigeria Tue, 07 Jul 2026 23:42:42 GMT
• ions (nasdaq: ions) brokered notice to sell 67,386 shares Stock Titan Tue, 07 Jul 2026 20:31:44 GMT
• Holly Kordasiewicz files Form 144 to sell 60,846 shares (IONS) Stock Titan Tue, 07 Jul 2026 20:30:42 GMT
• IONS Completes Enrollment in Pivotal Cohort of Angelman Syndrome Study Yahoo Finance Tue, 07 Jul 2026 16:28:00 GMT
• Ionis Pharmaceuticals concludes REVEAL study pivotal cohort enrolment Yahoo Tue, 07 Jul 2026 10:00:26 GMT
• the future of biotech? bridgebio, ionis and biomarin are worth watching Technology Org Tue, 07 Jul 2026 06:16:46 GMT
• Ionis Pharmaceuticals director Joseph Klein III sells $910k in stock Investing.com Tue, 07 Jul 2026 00:40:55 GMT
• amyotrophic lateral sclerosis market trends, innovation, and future growth outlook to 2036 – delveinsight | helixmith, sanofi, den... Barchart.com Tue, 07 Jul 2026 00:30:21 GMT
• ionis pharmaceuticals director joseph klein iii sells $910k in stock Investing.com UK Mon, 06 Jul 2026 22:54:00 GMT
• Ionis (NASDAQ: IONS) director receives $400K-capped RSUs and options grant Stock Titan Mon, 06 Jul 2026 22:51:16 GMT
• form 4 ionis pharmaceuticals inc for: 6 july by investing.com Investing.com Canada Mon, 06 Jul 2026 22:51:10 GMT
• Ionis (NASDAQ: IONS) awards director RSUs and stock options Stock Titan Mon, 06 Jul 2026 22:50:52 GMT
• Ionis (NASDAQ: IONS) director receives 2026 RSU and stock option grants Stock Titan Mon, 06 Jul 2026 22:50:24 GMT
• Ionis (NASDAQ: IONS) director exercises options, sells 11,518 shares under plan Stock Titan Mon, 06 Jul 2026 22:49:59 GMT
• Ionis (NASDAQ: IONS) director granted RSUs and stock options as 2026 pay Stock Titan Mon, 06 Jul 2026 22:46:07 GMT
• Ionis Pharmaceuticals (IONS) grants director RSUs and stock options Stock Titan Mon, 06 Jul 2026 22:44:28 GMT
• Ionis Pharmaceuticals (IONS) Could Be 19% Undervalued After REVEAL Study Enrollment Milestone simplywall.st Mon, 06 Jul 2026 20:41:28 GMT
• ionis pharmaceuticals (nasdaq: ions) has successfully completed patient enrollment for the pivotal cohort of its phase 3 reveal st... Bitget Mon, 06 Jul 2026 20:00:19 GMT
• ionis pharmaceuticals advances obudanersen for angelman syndrome GuruFocus Mon, 06 Jul 2026 16:54:08 GMT
• ionis finishes patient enrollment in phase 3 rare disease trial grafa.com Mon, 06 Jul 2026 15:20:00 GMT
• ionis pharmaceuticals, inc. completes enrollment in pivotal cohort of phase 3 reveal study evaluating obudanersen in angelman synd... marketscreener.com Mon, 06 Jul 2026 13:36:38 GMT
• ionis completes enrollment in angelman syndrome drug trial by investing.com Investing.com South Africa Mon, 06 Jul 2026 11:40:16 GMT
• ionis pharmaceuticals (ions) advances phase 3 reveal study for a GuruFocus Mon, 06 Jul 2026 11:37:38 GMT
• Ionis completes enrollment in pivotal cohort of the Phase 3 REVEAL study evaluating obudanersen in Angelman syndrome Business Wire Mon, 06 Jul 2026 11:00:00 GMT
• ionis pharmaceuticals, inc. (ions) stock analysis: exploring a 29.48% potential upside in the biotech sphere DirectorsTalk Interviews Mon, 06 Jul 2026 09:25:13 GMT
• ionis pharmaceuticals updates its antisense drug pipeline. ionis stock reflects long-term biotech ri Ad-hoc-news.de Fri, 03 Jul 2026 17:38:28 GMT
• TimesSquare Mid Cap Growth Strategy Picks Ionis Pharmaceuticals (IONS) on Clinical Momentum Yahoo Finance Thu, 02 Jul 2026 13:47:15 GMT
• the future of biotech? bridgebio, ionis and biomarin are worth watching Technology Org Thu, 02 Jul 2026 06:39:04 GMT
• form 144 ionis pharmaceuticals inc for: 1 july by investing.com Investing.com Canada Wed, 01 Jul 2026 21:37:08 GMT
• ionis’s tryngolza wins expanded approval for severe high triglycerides Новости GxP Wed, 01 Jul 2026 12:45:54 GMT
• ionis pharmaceuticals evp clo sells $245,520 in stock by investing.com Investing.com Australia Tue, 30 Jun 2026 22:40:51 GMT
• ionis pharmaceuticals evp schneider sells $2.1m in stock Investing.com Tue, 30 Jun 2026 22:15:30 GMT
• ionis pharmaceuticals evp joseph baroldi’s spouse sells $451,698 stock Investing.com Tue, 30 Jun 2026 22:12:44 GMT
• form 4 ionis pharmaceuticals inc for: 30 june by investing.com Investing.com Canada Tue, 30 Jun 2026 22:05:21 GMT
• spouse of ionis (nasdaq: ions) evp exercises options and sells shares Stock Titan Tue, 30 Jun 2026 21:49:00 GMT
• ionis pharmaceuticals (ions) evp exercises options and sells 26k shares Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• ionis grants recordati rights to zilganersen for alexander disease MSN Mon, 29 Jun 2026 08:43:51 GMT
• why ionis pharmaceuticals (ions) is up 9.5% after dual tryngolza approval and zilganersen out-licensing deal simplywall.st Mon, 29 Jun 2026 05:28:27 GMT
• the week in pharma: action, reaction and insight – week to june 26, 2026 The Pharma Letter Sun, 28 Jun 2026 10:22:44 GMT
• Ionis Pharmaceuticals (IONS) Signs Recordati Deal For Zilganersen Outside The U.S. Yahoo Finance Sun, 28 Jun 2026 07:00:00 GMT
• ionis (ions) wins tryngolza approval and recordati deal for zilganersen simplywall.st Sun, 28 Jun 2026 07:00:00 GMT
• ionis pharmaceuticals (ions) is up 9.5% after fda expands tryngolza label for severe hypertriglyceridemia Yahoo Finance Sun, 28 Jun 2026 03:11:00 GMT
• price to book forward of ionis pharmaceuticals, inc. – nasdaq:ions TradingView Sat, 27 Jun 2026 12:40:57 GMT
• price to earnings forward of ionis pharmaceuticals, inc. – nasdaq:ions TradingView Sat, 27 Jun 2026 11:39:14 GMT
• enterprise value to ebitda forward of ionis pharmaceuticals, inc. – nasdaq:ions TradingView Sat, 27 Jun 2026 10:33:56 GMT
• analysts offer insights on healthcare companies: abbvie (abbv) and ionis pharmaceuticals (ions) The Globe and Mail Sat, 27 Jun 2026 08:48:00 GMT
• insider sell: brett monia sells 85,637 shares of ionis pharmaceu GuruFocus Sat, 27 Jun 2026 08:00:51 GMT
• Ionis Pharmaceuticals (IONS) Is Up 9.5% After FDA Expands Tryngolza Label For Severe Hypertriglyceridemia Yahoo Finance Sat, 27 Jun 2026 07:00:00 GMT
• ionis (ions) wins tryngolza approval and recordati deal for zilganersen Sahm Sat, 27 Jun 2026 07:00:00 GMT
• enterprise value to ebit forward of ionis pharmaceuticals, inc. – nasdaq:ions TradingView Sat, 27 Jun 2026 05:48:08 GMT
Ionis Pharmaceuticals, Inc(NASDAQ:IONS) 
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis...
Website: http://www.ionispharma.com
Founded: 1989
Full Time Employees: 817
Sector: Healthcare
Industry: Biotechnology